Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking ; volume:18 ; number:1 ; day:23 ; month:5 ; year:2016 ; pages:1-9 ; date:12.2016
Arthritis Research & Therapy ; 18, Heft 1 (23.5.2016), 1-9, 12.2016
- Creator
-
Roos, Karin
- Contributor
-
Martinsson, Klara
Ziegelasch, Michael
Sommarin, Yngve
Svärd, Anna
Skogh, Thomas
Kastbom, Alf
SpringerLink (Online service)
- DOI
-
10.1186/s13075-016-1014-1
- URN
-
urn:nbn:de:1111-201605258283
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Roos, Karin
- Martinsson, Klara
- Ziegelasch, Michael
- Sommarin, Yngve
- Svärd, Anna
- Skogh, Thomas
- Kastbom, Alf
- SpringerLink (Online service)
Other Objects (12)
Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis
Presence of salivary IgA anti-citrullinated protein antibodies associate with higher disease activity in patients with rheumatoid arthritis
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis
Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
Secretory IgA impacts the microbiota density in the human nose
The role of IgA anti-citrullinated protein antibodies (ACPA) in rheumatoid arthritis and glycosylation differences of IgA subclasses.
Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study
Variability in gut mucosal secretory IgA in mice along a working day
Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis
Presence of salivary IgA anti-citrullinated protein antibodies associate with higher disease activity in patients with rheumatoid arthritis
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis
Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
Secretory IgA impacts the microbiota density in the human nose
The role of IgA anti-citrullinated protein antibodies (ACPA) in rheumatoid arthritis and glycosylation differences of IgA subclasses.
Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study
Variability in gut mucosal secretory IgA in mice along a working day
Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis
Presence of salivary IgA anti-citrullinated protein antibodies associate with higher disease activity in patients with rheumatoid arthritis
Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis
Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis
Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
Secretory IgA impacts the microbiota density in the human nose
The role of IgA anti-citrullinated protein antibodies (ACPA) in rheumatoid arthritis and glycosylation differences of IgA subclasses.
Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study